SC Filed 2020-06-08 Event — SEC 0001104659-20-070830 →

Lilly Ventures Fund I LLC → Protagonist Therapeutics, Inc PTGX

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

6 transactions

0 buys · 3 sales · 3 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-08-31

DTC 15.34

7,712,543 shares short · -1.0% vs prior

Institutional Consensus · 2026-06-30

Held by elite portfolio managers

2 holders · $8.76M

Duquesne Family OfficeSoros Fund Management

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-09-10	PATEL DINESH V PH D	director, officer	Option exercise	7,278	$21.58	$157K
2026-09-10	PATEL DINESH V PH D	director, officer	Sale	7,278	$144.10	$1.05M
2026-09-09	PATEL DINESH V PH D	director, officer	Option exercise	63,548	$21.58	$1.37M
2026-09-09	PATEL DINESH V PH D	director, officer	Sale	63,548	$146.18	$9.29M
2026-09-08	PATEL DINESH V PH D	director, officer	Option exercise	54,174	$21.58	$1.17M
2026-09-08	PATEL DINESH V PH D	director, officer	Sale	54,174	$145.87	$7.90M

Other 13D/G Filings on Protagonist Therapeutics, Inc

Filed	Form	Filer	Stake	Shares
2018-01-04	SC	ADAGE CAPITAL PARTNERS GP, L.L.C.	—	—	view →

Other Filings by Lilly Ventures Fund I LLC

Filed	Form	Issuer	Stake	Shares
2019-08-13	SC	AILERON THERAPEUTICS INC RNTX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →